Novais and colleagues, in their 2013 study, discussed that cytolytic CD8+ T cells mediate immunopathology and drive the development of metastatic lesions in cutaneous Leishmaniasis [41]. The gene discussed is CD8A; the disease is cutaneous leishmaniasis.